Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma
Clinical trial NCT02131480 · COMPLETED
Trial details
- NCT number
- NCT02131480
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-01-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.